is classified into 2 subtypes, PHP-Ia and -Ib, according to the molecular causes and clinical features of the patients [1] . PHP-Ia results from loss-of-function mutations in the maternally derived GNAS gene that encodes the stimulatory G protein α-subunit [1] . Patients with PHP-Ia manifest multiple hormone resistance and characteristic physical stigmata such as short stature, obesity, round face, brachydactyly, subcutaneous ossification, and mild to moderate mental retardation, which are collectively referred to as Albright's hereditary osteodystrophy (AHO) [1, 2] .
PHP-Ib is caused by imprinting defects of the maternally derived GNAS allele; patients with this condi-creatine kinase (CK) level was markedly elevated. An Ellsworth-Howard test showed impaired responses of both urinary phosphaturic and cyclic AMP levels ( Table  1 ). The TSH level was slightly elevated, while free T4 and gonadotropin levels were within the normal range. The serum 1,25-dihydroxy vitamin D (1,25(OH)2D) level was mildly elevated. Head computerized tomography (CT) delineated symmetric calcifications of the basal ganglia and thalami, and subcortical calcification of the right middle frontal gyrus. Dual-energy X-ray absorptiometry (DEXA) revealed decreased bone mineral density at the lumbar spine (L2-L4) (0.640 g/cm 2 , -2.9 SD). Based on these data, we diagnosed him as having PHP-Ib with neuromuscular symptoms. After 1 month of treatment with alfacalcidol (1.5 µg/day) and calcium lactate (3.0 g/day), his general fatigue, gait disturbance, and myalgia were markedly improved.
The 15-year-old brother of the patient manifested no clinically discernible phenotype; the brother had no gait disturbance or muscle weakness. Furthermore, physical examinations revealed neither muscular atrophy nor neurologic abnormalities. However, laboratory examinations detected an elevated serum intact PTH level, although serum calcium level was within the normal range (Table 1) . Thus, the brother was also suspected as having PHP-Ib. The brother manifested mildly elevated serum 1,25(OH)2D level.
The 50-year-old father and 17-year-old sister were clinically normal. The mother, deceased at 49 years of age of an unknown cause, allegedly had no clinical symptoms indicative of PHP. Endocrine studies revealed no abnormalities in the father, sister, or mother (Table 1) .
Molecular analyses
This study was approved by the Institutional Review Board Committee at the National Center for Child Health. After obtaining written informed consent, we extracted genomic DNA from leukocytes of the patient and his brother and father.
We examined mutations in the coding region of GNAS by direct sequencing, and copy number alternations and methylation defects in the GNAS-flanking region by methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA), using a commercially available probe mix (SALSA MLPA kit, ME031-A1) (MRC-Holland, Amsterdam, The Netherlands). To confirm the results of MS-MLPA, we performed PCR analyses using forward and reverse tion show hypomethylation at one or more of the 4 differentially methylated regions (DMRs) of GNAS [3] [4] [5] [6] [7] . Genetic causes of PHP-Ib include cryptic deletions within the genes neighboring GNAS, STX16 and NESP55, and epimutation of GNAS DMRs [4, 5] . Patients with PHP-Ib manifest PTH resistance without AHO [1] . These patients are usually identified by hypocalcemia-associated neuromuscular irritability, such as tetany, generalized convulsions, and/or muscle cramps, although a substantial fraction of the patients remain asymptomatic and are identified only by familial studies [6, 7] .
Previous studies of patients with primary hypoparathyroidism have shown that hypocalcemia can be associated with various types of neuromuscular symptoms [8, 9] . However, such clinical features have been rarely described in patients with PHP-Ib [10] . Here, we report a Japanese patient with familial PHP-Ib due to an intragenic deletion of STX16, who presented with unique neuromuscular symptoms.
methods

Case report
This male patient was born as the third child to nonconsanguineous Japanese parents at 39 weeks of gestation, after an uncomplicated pregnancy and delivery. His birth weight was 3482 g (+1.1 SD) and length 50 cm (+0.7 SD). Neonatal screening tests were normal. His postnatal growth and development were uneventful.
From the age of 6 years, he had general fatigue. At 12 years of age, he was seen by a local doctor because of general fatigue, gait disturbance, and myalgia in the lower legs. He was suspected to have congenital myopathy, and was referred to our clinic for further investigation. His height and weight at the time of examination were 161.4 cm (+1.1 SD) and 42.4 kg (-0.2 SD), respectively. Physical examinations revealed muscular atrophies with weakness in the lower legs, a shortening of the bilateral Achilles' tendons and absence of deep tendon reflexes. He showed a high stepping gait with markedly reduced strength of dorsiflexors of the ankles. Sense of touch and temperature was normal. The Chvostek's sign was positive, while the Trousseau's sign was negative. He had neither AHO stigmata nor episodes of tetany or convulsions. Laboratory examinations revealed hypocalcemia, hyperphosphatemia, and an elevated serum intact PTH level, together with decreased urinary calcium excretions (Table 1) . Serum (Fig. 1C) . The microdeletion and methylation defect were also observed in the brother, but not in the father. DNA samples of the mother and the sister were not available for genetic analyses.
discussion
We report here a Japanese patient with PHP-Ib, who was identified by general fatigue, gait disturbance, and myalgia in the lower legs. He showed muscular atrophies in the lower legs, a shortening of the bilateral Achilles' tendons, absence of deep tendon reflexes, and an elevated serum CK value. Such clinical features are indicative of neuromuscular symptoms, although a detailed neurological workup was not performed for primers that hybridize to introns 3 and 6 of STX16, respectively [4] .
results
Direct sequence analysis for the patient identified no mutation in the coding region of GNAS. However, MS-MLPA revealed decreased peak heights of probes that correspond to exons 5 and 6 of STX16, indicating a heterozygous deletion within STX16. In addition, MS-MLPA indicated hypomethylation at GNAS exon A/B and a normal methylation pattern of the other 3 GNAS DMRs (Fig. 1A, B) . Subsequent PCR analyses showed the presence of a heterozygous 3 kb deletion involving exons 4-6 of STX16 (STX16∆exons 4-6) hypothesis. However, we cannot exclude the possibility that other factors such as vitamin D deficiency may also have played a role in the development of these features. Indeed, slightly elevated serum levels of ALP and 1,25(OH)2D in the patient are consistent with mild vitamin D deficiency [12] . On the other hand, since serum 1,25(OH)2D levels were similarly elevated in the patient and his asymptomatic brother, phenotypic variation in this family can not be explained by vitamin D deficiency. These results indicate that neuromuscular features probably associated with hypocalcemia can be the first symptoms of PHP-Ib. Nevertheless, this notion is based on observations of a single case, and this patient. In this regard, it is noteworthy that peripheral neuropathy and metabolic myopathy have been reported in patients with primary hypoparathyroidism [8, 9] , whereas such symptoms have not been described in patients with PHP, except for mildly elevated blood CK and lactate dehydrogenase (LDH) levels in a single case of PHP-Ia [10] . Moreover, in vitro experiments showed that calcium concentration affects excitability at neuromuscular junctions [11] . Thus, the neuromuscular symptoms of our patient are likely to be associated with hypocalcemia. A significant improvement in the clinical features of the patient after 1 month of treatment with alfacalcidol and calcium supports this cium levels are not sufficient to identify patients with PHP-Ib, and that genetic analyses or detailed endocrine evaluations, such as measurement of intact PTH levels and an Ellsworth-Howard test, are necessary for patients with atypical manifestations. In this context, although STX16∆exons4-6mat is the most frequent genetic cause of familial PHP-Ib [7] , microdeletions affecting NESP55 as well as epimutations of GNAS DMR also account for etiology of PHP-Ib [5, 7] . Since MS-MLPA is capable of detecting both copy number abnormalities and methylation defects in the GNAS-flanking region in a single assay, this method should be particularly useful for the molecular diagnosis of PHP-Ib. In summary, the present study provides that various neuromuscular features probably associated with hypocalcemia can be the first symptoms of PHP-Ib, and suggests that MS-MLPA serves as a powerful tool for screening of GNAS abnormalities in patients with atypical manifestations.
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requires further investigations.
Both the patient and his brother carried a heterozygous STX16∆exons4-6. Although DNA samples of the mother were not available for genetic analyses, the absence of the deletion in the father indicated the maternal inheritance of the deletion. It has been shown that maternally inherited STX16∆exons4-6 (STX16∆exons4-6mat) is associated with hypomethylation at GNAS exon A/B, whereas GNAS epimutations are usually accompanied by methylation defects not only at exon A/B but also at other GNAS DMRs [3, 7] . These results suggest that the 3 kb region around exon 4-6 of STX16 contains a cis-acting element that regulates methylation status at GNAS exon A/B. Consistent with this, our patient and his brother had methylation defects exclusively at exon A/B. Further studies are necessary to clarify the mechanism by which a DNA element >200 kb from GNAS controls the methylation status at exon A/B.
Clinical severities of patients with PHP-Ib are known to be variable [6, 7] . Notably, Linglart et al. have shown that STX16∆exons4-6mat is often associated with a mild phenotype. They found that about 40% of patients carrying this microdeletion remained asymptomatic, and more than 50% of asymptomatic individuals had normocalcemia at the time of diagnosis [7] . Consistent with this, our patient and his brother lacked typical PHP-Ib features such as tetany, generalized convulsions, or muscle cramps. Furthermore, the brother had normocalcemia. These results suggest that physical examinations and measurement of serum calreferences
